Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Early balding at 40 increases prostate cancer risk.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Antiandrogen therapy helps treat genetic hair loss.

PRP therapy and minoxidil combo works best for male hair loss.

Alternative treatments show promise for hair growth beyond traditional methods.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Various treatments exist for hair loss, but more research is needed for better options.

Kimchi probiotics slightly improved hair density, but more research needed.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Finger length ratio may indicate male hair loss.

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

Men with hair loss may lack zinc, copper, and vitamin D; supplements could help.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Herbal solution improves hair diameter and density more than 5% minoxidil for androgenetic alopecia.

Various treatments help hair growth, but more research needed for safety and effectiveness.

Better hair loss models needed for research.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.